Eagle Health Investments as of March 31, 2024
Portfolio Holdings for Eagle Health Investments
Eagle Health Investments holds 27 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera (NTRA) | 10.8 | $58M | 633k | 91.46 | |
Icon SHS (ICLR) | 9.3 | $50M | 150k | 335.95 | |
Illumina (ILMN) | 8.1 | $44M | 319k | 137.32 | |
United Therapeutics Corporation (UTHR) | 7.7 | $41M | 180k | 229.72 | |
Dex (DXCM) | 7.3 | $40M | 285k | 138.70 | |
Argenx Se Sponsored Adr (ARGX) | 6.2 | $33M | 85k | 393.72 | |
Iqvia Holdings (IQV) | 5.7 | $31M | 122k | 252.89 | |
Danaher Corporation (DHR) | 5.3 | $28M | 114k | 249.72 | |
Inspire Med Sys (INSP) | 4.9 | $26M | 122k | 214.79 | |
Transmedics Group (TMDX) | 3.8 | $21M | 279k | 73.94 | |
Procept Biorobotics Corp (PRCT) | 3.1 | $17M | 337k | 49.42 | |
Guardant Health (GH) | 2.8 | $15M | 730k | 20.63 | |
4d Molecular Therapeutics In (FDMT) | 2.7 | $15M | 463k | 31.86 | |
Intuitive Surgical Com New (ISRG) | 2.6 | $14M | 36k | 399.09 | |
Ultragenyx Pharmaceutical (RARE) | 2.6 | $14M | 300k | 46.69 | |
Crispr Therapeutics Namen Akt Put Option (CRSP) | 2.5 | $13M | 197k | 68.16 | |
Sarepta Therapeutics (SRPT) | 2.5 | $13M | 103k | 129.46 | |
Fusion Pharmaceuticals | 2.3 | $12M | 580k | 21.32 | |
Agios Pharmaceuticals (AGIO) | 1.8 | $9.7M | 331k | 29.24 | |
EXACT Sciences Corporation (EXAS) | 1.6 | $8.4M | 121k | 69.06 | |
Pacific Biosciences of California (PACB) | 1.5 | $8.1M | 2.2M | 3.75 | |
Alnylam Pharmaceuticals (ALNY) | 1.3 | $7.2M | 48k | 149.45 | |
10x Genomics Cl A Com (TXG) | 0.9 | $5.1M | 135k | 37.53 | |
Werewolf Therapeutics (HOWL) | 0.8 | $4.5M | 700k | 6.48 | |
Viking Therapeutics (VKTX) | 0.7 | $3.7M | 45k | 82.00 | |
Immunocore Hldgs Ads (IMCR) | 0.6 | $3.0M | 46k | 65.00 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.5 | $2.7M | 43k | 62.24 |